Spyre Therapeutics
SYRE
#4522
Rank
HK$13.77 B
Marketcap
HK$270.48
Share price
3.29%
Change (1 day)
206.07%
Change (1 year)

Spyre Therapeutics (SYRE) - Total debt

Total debt on the balance sheet as of December 2023 : N/A

According to Spyre Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Spyre Therapeutics - Total debt on balance sheet (from 2018 to 2023)

Total debt by year

Year Total debt Change
2023-12-31N/A-100%
2022-12-31HK$36.16 M-8.33%
2021-12-31HK$39.45 M-6.58%
2020-12-31HK$42.23 M7.11%
2019-12-31HK$39.43 M
2018-12-31N/A